<DOC>
	<DOCNO>NCT00727649</DOCNO>
	<brief_summary>The purpose study evaluate compare treatment fiber loperamide fecal incontinence .</brief_summary>
	<brief_title>Efficacy Mechanisms Pharmacologic Treatment Fecal Incontinence</brief_title>
	<detailed_description>Fecal incontinence ( FI ) affect 4-24 % adult community greatly impact quality life . Both fiber loperamide common , first-line treatment diarrhea-associated FI primary care . No known study exist compare fiber loperamide diarrhea-predominant FI . Further knowledge need define treatment effective compare drug tolerability ( side effect ) FI . This study also look change quality life treatment potential mechanisms drug treatment .</detailed_description>
	<mesh_term>Fecal Incontinence</mesh_term>
	<mesh_term>Loperamide</mesh_term>
	<mesh_term>Antidiarrheals</mesh_term>
	<mesh_term>Calcium polycarbophil</mesh_term>
	<mesh_term>Psyllium</mesh_term>
	<criteria>weekly fecal incontinence fecal impaction inability complete baseline 1week bowel diary rectal prolapse prior radiation pelvis colorectal cancer rectal fistula inflammatory bowel disease neurological disease ( spinal cord injury , multiple sclerosis , Parkinson 's disease ) constipation ( &lt; 2 bowel movements/week ) total colectomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>fecal incontinence</keyword>
	<keyword>adult</keyword>
	<keyword>diarrhea</keyword>
</DOC>